Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial.

MLA

Holfeld, Johannes, et al. “Cardiac Shockwave Therapy in Addition to Coronary Bypass Surgery Improves Myocardial Function in Ischaemic Heart Failure: The CAST-HF Trial.” European Heart Journal, vol. 45, no. 29, Aug. 2024, pp. 2634–43. EBSCOhost, https://doi.org/10.1093/eurheartj/ehae341.

APA

Holfeld, J., Nägele, F., Pölzl, L., Engler, C., Graber, M., Hirsch, J., Schmidt, S., Mayr, A., Troger, F., Pamminger, M., Theurl, M., Schreinlechner, M., Sappler, N., Ruttmann-Ulmer, E., Schaden, W., Cooke, J. P., Ulmer, H., Bauer, A., Gollmann-Tepeköylü, C., & Grimm, M. (2024). Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial. European Heart Journal, 45(29), 2634–2643. https://doi.org/10.1093/eurheartj/ehae341

Chicago

Holfeld, Johannes, Felix Nägele, Leo Pölzl, Clemens Engler, Michael Graber, Jakob Hirsch, Sophia Schmidt, et al. 2024. “Cardiac Shockwave Therapy in Addition to Coronary Bypass Surgery Improves Myocardial Function in Ischaemic Heart Failure: The CAST-HF Trial.” European Heart Journal 45 (29): 2634–43. doi:10.1093/eurheartj/ehae341.